Retinyl palmitate added to Fe-fortified maize bread has been reported to enhance Fe absorption in adult Venezuelan subjects but not in Western Europeans. It is not known to what extent these results were influenced by differences in vitamin A status of the study subjects. The objective of the present study was to evaluate the influence of retinyl palmitate added to Fe-fortified maize porridge on erythrocyte incorporation of Fe in children with vitamin A deficiency, before and after vitamin A supplementation. Erythrocyte incorporation of Festable isotopes was measured 14 d after intake of maize porridge (2·0 mg Fe added as ferrous sulfate) with and without added retinyl palmitate (3·5 mmol; 3300 IU). The study was repeated 3 weeks after vitamin A supplementation (intake of a single dose of 210 mmol retinyl palmitate; 'vitamin A capsule'). Vitamin A status was evaluated by the modified relative dose -response (MRDR) technique. Retinyl palmitate added to the test meal reduced the geometric mean erythrocyte incorporation of Fe at baseline from 4·0 to 2·6 % (P¼0·008, n 13; paired t test). At 3 weeks after vitamin A supplementation, geometric mean erythrocyte incorporation was 1·9 and 2·3 % respectively from the test meal with and without added retinyl palmitate (P¼0·283). Mean dehydroretinol:retinol molar ratios were 0·156 and 0·125 before and after intake of the single dose of 210 mmol retinyl palmitate; 'vitamin A capsule' (P¼0·15). In conclusion, retinyl palmitate added to the labelled test meals significantly decreased erythrocyte incorporation of Fe in children with vitamin A deficiency at baseline but had no statistically significant effect 3 weeks after vitamin A supplementation. The difference in response to retinyl palmitate added to Fe-fortified maize porridge on erythrocyte incorporation of Fe before and after intake of the vitamin A capsule indicates, indirectly, changes in vitamin A status not measurable by the MRDR technique. The lack of conclusive data on the effect of retinyl palmitate on Fe absorption indicates the complexity of the interactions between vitamin A status, dietary vitamin A and Fe metabolism. 
Interactions between vitamin A and Fe metabolism have been demonstrated in several human studies and the current knowledge of the effect of vitamin A on haematological indicators was recently reviewed by Fishman et al. (2000) and by Semba & Bloem (2002) . Substantial evidence exists that vitamin A deficiency is associated with anaemia and that vitamin A supplementation also can be expected to increase haemoglobin (Hb) concentrations in anaemic children and pregnant women. The mechanisms by which vitamin A deficiency induces anaemia have not been clearly demonstrated but have been suggested to include impaired differentiation and proliferation of haematopoietic cells, disturbed erythropoietin synthesis, reduced mobilisation of body Fe stores and/or effects on Fe metabolism through sequestration of Fe during the acute-phase response to infection (for reviews, see Fishman et al. 2000; Semba & Bloem, 2002) .
In addition, interactions between vitamin A and Fe, resulting in enhanced Fe absorption in human subjects, have been suggested (Layrisse et al. 1997; Garcia-Casal et al. 1998) . The enhancing effect of retinyl palmitate on Fe absorption reported in adult Venezuelan peasants was recently evaluated but not confirmed in healthy Western European adults (Walczyk et al. 2003) . The reasons for the contradictory results reported from Latin America and Europe are unknown. Although a number of differences in the experimental design can be identified between the two study sites, all studies were based on the measurement of erythrocyte incorporation of Fe isotopes (radioactive or stable) as a proxy for Fe absorption. However, differences in nutritional status between the study populations can be speculated to have influenced the results. Until now, no information has been available on the effect of retinyl palmitate on erythrocyte incorporation of Fe in individuals with vitamin A deficiency.
The aim of the present study was to evaluate the effect of retinyl palmitate on erythrocyte incorporation of Fe from a test meal based on maize porridge in African schoolchildren with vitamin A deficiency, before and after supplementation with 210 mmol (200 000 IU) retinyl palmitate. Nutritional status was evaluated by the modified relative dose -response (MRDR) technique and by plasma transferrin receptor (TfR) concentration, respectively, as these indicators of vitamin A and Fe status have been demonstrated not to be influenced by infections (Tanumihardjo et al. 1996b; Staubli Asobayire et al. 2001; Wieringa et al. 2002) . Erythrocyte incorporation of Fe stable isotopes was measured 14 d after intake of labelled test meals (2·0 mg Fe added as ferrous sulfate), served with and without added retinyl palmitate (3·5 mmol; 3300 IU).
Subjects and methods

Subjects
The sample size was based on previous data on erythrocyte incorporation of Fe in infants . It was estimated that ten children would be a sufficient sample size to detect a nutritionally significant difference in erythrocyte incorporation of 50 % with 90 % power and a type I error rate of 5 %. Thirteen children were included to allow for dropouts. The study was implemented in the northern part of Côte d'Ivoire, in a region where a high prevalence (34 %) of low plasma retinol concentration (, 0·7 mmol/l) in schoolchildren, indicating vitamin A deficiency in this population group (Sommer & Davidson, 2002) , had been observed in a previous survey (Staubli Asobayire, 2000) . Based on an initial screening study by the Institut National de Santé Publique, Abidjan, thirteen schoolchildren living in one of the villages included in our previous study of nutritional status (Staubli Asobayire et al. 2001 ) with low plasma retinol (, 0·7 mmol/l) were invited to participate in the study. All children were enrolled in the study at the same time. Children, their parents and/or guardians and their teachers were fully informed about the aims and procedure of the study. Informed oral consent was obtained from at least one parent or guardian of each child. Oral consent was obtained from the village chief. At the end of the study, children with Fe deficiency or Fe-deficiency anaemia were treated with medicinal Fe. As distribution of vitamin A capsules is irregular in this region, all schoolchildren in the village were given a single dose of 210 mmol (200 000 IU) retinyl palmitate at the end of the study.
The study protocol was reviewed and approved by the ethical committee of the Children's Hospital, Zürich and by the Institut National de Santé Publique, Abidjan. (Layrisse et al. 1997; Garcia-Casal et al. 1998; Walczyk et al. 2003) . A working solution of retinyl palmitate was prepared each day by mixing pre-weighed quantities of retinyl palmitate and water. Individual doses were added to the test meals immediately before consumption. Each test meal was administered twice, on four consecutive days, after an overnight fast. Test meal A (without added retinyl palmitate; labelled with 57 Fe) was served on days 1-2 and test meal B (with added retinyl palmitate; labelled with 58 Fe) on days 3 and 4. Mineral water (Volvic; Danone, Paris, France) was used for preparation of test meals and served as a drink (200 g). As one hypothesis was that retinyl palmitate could influence Fe absorption at the mucosal level, the feeding of meals 1 and 2 in a random order was considered inappropriate. All meals were fed under close supervision and no food or drink was allowed for 3 h following intake of test meals.
Test meals and study design
On day 19, the content of a vitamin A capsule (210 mmol retinyl palmitate, 200 000 IU; Hoffmann LaRoche) was squeezed directly into the mouth of each child. At 3 weeks later, a venous blood sample was drawn and labelled test meals with and without added retinyl palmitate were administered in an identical manner as during the first part of the study. The final blood sample was drawn 14 d after intake of the last test meal (day 57).
Modified relative dose -response test
Vitamin A status was evaluated by the MRDR test according to Tanumihardjo et al. (1996a) on days 18 and 57. After an overnight fast, each child was given 7·0 mmol (2·0 mg) 3,4-didehydroretinol (vitamin A 2 ) dissolved in oil. Doses of 3,4-didehydroretinol (225 ml) were administered directly into the mouth, using a Gilson Microman pipette with positive displacement mechanism (Gilson, Villiers-le-Bel, France). A high-fat snack (peanut butter sandwiches) was served after intake of 3,4-didehydroretinol. Venous blood samples were drawn 4 -5 h later. Molar ratios of dehydroretinol:retinol (DR:R)$ 0·06 were used to define vitamin A deficiency.
Blood sampling and analyses
Venous blood (5 ml) was collected in EDTA-treated vacutainer tubes at each sampling. Baseline blood samples were drawn at the start of the study (day 1) and on day 40 (second baseline). In addition, blood samples were drawn on days 18 and 57 (14 d after intake of the last test meal in each series of studies). Blood samples were kept cool and protected against light until separation of plasma. Hb was determined in duplicate by the cyanomethaemoglobin method (Sigma Diagnostic Kits, St Louis, MO, USA). A three-level quality-control material (Dia-HT-1,2,3; Diamed AG, Cressier sur Morat, Switzerland) was analysed in parallel.
Plasma samples were transported to Zürich frozen (2 208C) and protected against light until analysis. Plasma retinol was analysed by HPLC (Merck-Hitachi, Tokyo, Japan) on a reversed-phase column (Hypersil ODS RP-18 200 £ 4·6 mm, 3 mm; Crom, Herrenberg-Kayh, Germany) according to Tanumihardjo et al. (1994a) . A commercial reference material (NIST 968c; National Institute of Standards and Technology, Gaithersburg, MD, USA) was analysed together with the plasma samples. CV for retinol and 3,4-didehydroretinol analyses were 5 and 12 % respectively. The concentration of circulating TfR was measured by ELISA, using a commercial kit (Ramco Laboratories, Houston, TX, USA). The CV for TfR analysis was 4 %.
Stable-isotope labels
Stable-isotope solutions were prepared from isotopically enriched elemental Fe (Chemgas, Boulogne, France) by dissolution in diluted H 2 SO 4 . The isotopic composition of Fe solutions was determined by negative thermal ionisation -MS, using a magnetic sector instrument (MAT 262; Finnigan MAT, Bremen, Germany). Fe concentrations of the solutions were determined by isotope dilution MS against a diluted commercially available Fe standard (Titrisol; Merck, Darmstadt, Germany).
Individual doses (2·0 mg 57 Fe and 1·75 mg 58 Fe per administration) were prepared by weighing the corresponding amounts of solution into Teflon containers. Containers were flushed with Ar to avoid oxidation. Fe with normal isotopic composition (FeSO 4 ; Merck) was added to the 58 FeSO 4 solution to a total content of 2·0 mg Fe per dose.
Analysis of isotopic composition of blood samples
Blood samples were analysed in duplicate for Fe isotopic composition under chemical blank monitoring. Sampling handling was done under clean laboratory conditions to reduce the risk of sample contamination. Whole blood samples were mineralised in a HNO 3 -H 2 O 2 mixture, using microwave digestion. Fe was separated from the matrix by anion-exchange chromatography following a solvent/solvent extraction step into diethyl ether (Beer & Heumann, 1993; Kastenmayer et al. 1994) . All isotopic analyses were performed by negative thermal ionisation -MS according to Walczyk (1997) using a magnetic sector field mass spectrometer (MAT 262; Finnigan MAT) equipped with a multi-collector system for simultaneous ion beam detection. Because of the high enrichment of the stable-isotope labels and the low amounts of 57 
Calculation of iron erythrocyte incorporation
Based on the shift in Fe isotope ratios in blood samples and the amount of Fe circulating in the body, the amounts of 57 Fe label and 58 Fe label present in the blood 14 d after test meal administration were calculated. Calculations were based on principles of isotope dilution and considered that the Fe stable-isotope labels were not mono-isotopic (Walczyk et al. 1997) . Circulating Fe was calculated based on blood volume and Hb concentration, as described by Kastenmayer et al. (1994) . Blood volume calculations were based on height and weight according to Linderkamp et al. (1977) . Corrections were made for the altered baseline Fe isotope ratios during the second phase of the study.
Food analysis
Fe and Ca in the test meal were analysed by atomic absorption spectrometry (SpectrAA 400; Varian, Mulgrave, Australia) using a standard addition technique after digestion in a microwave system (MLS 1200; MLS GmbH, Leutkirck, Germany) in a mixture of HNO 3 -H 2 O 2 . Phytic acid (inositol hexaphosphate) was measured by HPLC according to Sandberg & Ahderinne (1986) . CV for Fe, Ca and phytic acid analyses were 5, 3 and 4 % respectively.
Statistics
Paired t tests were used for the evaluation of data, i.e. for comparisons of Hb, TfR, plasma retinol concentrations and DR:R ratios at different time points as well as for comparisons of erythrocyte incorporation of Fe from test meals with and without added retinyl palmitate at baseline and 3 weeks after intake of the vitamin A capsule. In addition, paired t tests were used to compare erythrocyte incorporation of Fe from test meals without added retinyl palmitate at baseline and 3 weeks after intake of the vitamin A capsule as well as to compare erythrocyte incorporation of Fe from test meals with added retinyl palmitate at the two time points. Fe erythrocyte incorporation data were logtransformed before statistical analysis and are presented as geometric means +1 SD, 2 1 SD. Other results are presented as arithmetic means and standard deviations.
Results
Four girls and nine boys (6 -13 years old) participated in the study. Fe status did not change significantly during the study. Hb concentration was 110 (SD 8) g/l at baseline and 106 (SD 11) g/l at the second baseline (day 40, P¼ 0·179); six and eight children were anaemic (Hb, 110 g/l) at baseline and on day 40 (Table 1) . TfR concentration was 9·3 (SD 3·3) and 8·8 (SD 2·8) mg/l at these two time points (P¼ 0·255); seven children were Fe-deficient (TfR. 8·5 mg/l) ( Table 1) . Five children were Fe-deficient anaemic (Hb, 110 g/l and TfR. 8·5 mg/l) on days 1 and 40. Individual values for plasma retinol and MRDR are presented in Table 2 . At each time point, seven to nine children had plasma retinol concentration below 0·7 mmol/l. Plasma retinol at baseline (0·659 (SD 0·182) mmol/l) was not significantly different from plasma retinol on day 40 (0·650 (SD 0·202) mmol/l; P¼ 0·80). Vitamin A deficiency was clearly demonstrated as all children had elevated DR:R ratios ($ 0·06) on day 18. Vitamin A liver stores were not improved significantly after vitamin A supplementation (intake of a single dose of 210 mmol retinyl palmitate; 'vitamin A capsule'). Mean DR:R decreased from 0·156 (day 18) to 0·125 (day 57), but this difference was not statistically significant (P¼ 0·15). On day 57, only one child had a DR:R ratio# 0·06.
Each test meal contained 0·19 mg native Fe, 20 mg Ca and 160 mg phytic acid (inositol hexaphosphate). Individual values for erythrocyte incorporation of Fe from the test meal, without and with added retinyl palmitate, are presented in Table 1 . At baseline, erythrocyte incorporation of Fe was significantly lower from the test meal with added retinyl palmitate (geometric mean 2·6 v. 4·0 %; P¼ 0·008). No significant difference in erythrocyte incorporation of Fe from test meals with or without added retinyl palmitate was observed when the study was repeated 3 weeks after the intake of a single dose of 210 mmol retinyl palmitate ('vitamin A capsule'; geometric mean 1·9 v. 2·3 %, 0·636  0·171  0·378  0·587  0·190  2  0·629  0·626  0·183  0·517  0·580  0·162  3  0·468  0·510  0·168  0·514  0·440  0·091  4  0·374  0·409  0·172  0·559  0·476  0·134  5  0·486  0·479  0·199  0·577  0·458  0·245  6  0·741  0·909  0·120  0·741  0·976  0·131  7  0·643  0·636  0·125  0·615  0·643  0·098  8  0·657  0·353  0·321  0·413  0·958  0·078  9  0·787  0·762  0·180  0·671  0·783  0·136  10  0·608  0·664  0·060  0·769  0·664  0·057  11  1·066  1·224  0·076  1·115  0·860  0·086  12  0·829  0·846  0·113  0·909  0·993  0·086  13  0·759  0·948  0·134  0·671  0·836  0·130  Mean  0·659  0·692  0·156  0·650  0·712  0·125   SD   0·182  0·243  0·065  0·202  0·201  0·052 ID, identification number. * For details of subjects and procedures, see The results from the present study, as well as those from our earlier study in healthy, adult Europeans (Walczyk et al. 2003) , are not in agreement with the reports about an enhancing effect of retinyl palmitate on Fe absorption from Venezuela (Layrisse et al. 1997; Garcia-Casal et al. 1998) . The significantly decreased erythrocyte incorporation of Fe from the test meal with added retinyl palmitate at baseline in the present study was surprising. However, the lack of any statistically significant effect of added retinyl palmitate on erythrocyte incorporation of Fe as observed after vitamin A supplementation (intake of a single dose of 210 mmol retinyl palmitate) in the present study is in agreement with our previous finding in adult Europeans.
In the previous human studies of the effect of added retinyl palmitate on Fe absorption reported by us (Walczyk et al. 2003) and by Layrisse and colleagues (Layrisse et al. 1997; Garcia-Casal et al. 1998) , erythrocyte incorporation of Fe isotopes 14 d after intake was used as a proxy for Fe absorption. This technique was first established for radioactive isotopes (Cook et al. 1972; Hallberg & Björn-Rasmussen, 1972) and later for stable isotopes to enable studies in infants and children ). The methodology is based on the assumption that a major, and constant, fraction (typically 80-90 %) of newly absorbed Fe isotopes is incorporated into erythrocytes within 14 d. Although very little is known about the mechanisms of the interactions between vitamin A status and Fe utilisation, the observation that erythrocyte incorporation of injected 59 Fe was significantly reduced in vitamin A-deficient animals (Mejia et al. 1979 ) is important in this context. No information is available on the incorporation rate of newly absorbed Fe into erythrocytes in individuals with vitamin A deficiency, before and after vitamin A supplementation. This measurement was not included in the present study, as the protocol would have required the injection of an additional stable isotope of Fe. The present study therefore reports erythrocyte incorporation of Fe without applying any incorporation factor to convert the values to Fe absorption. However, it is important to stress that measurements of erythrocyte incorporation of Fe represent the final result of several stages in Fe metabolism, including absorption and transport of Fe as well as erythropoiesis per se. Thus, the mechanism(s) of the influence of retinyl palmitate added to the diet and/or the influence of vitamin A status on one or more of these steps cannot be studied with the technique used in the present study or in the previous studies of the influence of retinyl palmitate on Fe absorption (Layrisse et al. 1997; Garcia-Casal et al. 1998; Walczyk et al. 2003) . Earlier studies in rats have reported contradictory data on the effects of vitamin A deficiency on Fe metabolism, indicating increased Fe absorption and retention (Amine et al. 1970; Roodenburg et al. 1994) or no difference in Fe absorption as compared with control animals (Mejia et al. 1979) . In these animal experiments, Fe absorption was measured by whole-body counting (Amine et al. 1970; Mejia et al. 1979) , measurements of faecal radioactivity (Mejia et al. 1979) or by the metabolic balance technique (Roodenburg et al. 1994) . The conflicting results can probably be ascribed to differences in experimental design and/or to differences in vitamin A status of animals in the separate studies. It is interesting to note that differences in the distribution of Fe were observed between vitamin A-deficient and normal animals. For example, vitamin A-deficient animals accumulated more Fe in liver (Mejia et al. 1979) and spleen (Mejia et al. 1979; Roodenburg et al. 1994 ) than did healthy animals. Such differences in the metabolism of newly absorbed Fe could be important factors also in the present study. However, there is no information available on the distribution of Fe in different organs related to vitamin A status in man.
An additional methodological constraint in the present study was the lack of sensitive techniques to monitor changes in vitamin A status. Plasma retinol concentrations are well known to be depressed by infections (Willumsen et al. 1997; Wieringa et al. 2002) and are therefore of limited value to identify vitamin A deficiency in individuals living in poor, rural communities such as the study site in the present study. A high prevalence of elevated C-reactive protein concentrations and helminth and malaria infections has recently been reported in school children living in this region (Staubli Asobayire, 2000; Staubli Asobayire et al. 2001) . The children participating in the present study showed no obvious signs of current infection or other health problems during the study but minor infections can be assumed to be prevalent. For practical reasons, the study population was selected based on low plasma retinol concentrations during a screening study about 6 -8 weeks before the start of the present study. At baseline, eight children had plasma retinol below 0·7 mmol/l and the number of children with low plasma retinol remained relatively stable throughout the study; seven to nine children had low plasma retinol (, 0·7 mmol/l) at each blood sampling.
The usefulness of the MRDR technique to evaluate vitamin A status in children in developing countries has been demonstrated previously (Tanumihardjo et al. 1990 (Tanumihardjo et al. , 1994b (Tanumihardjo et al. , 1996a Wieringa et al. 2002) . Most importantly, this status indicator has been demonstrated not to be influenced by infections (Tanumihardjo et al. 1996b; Wieringa et al. 2002) and the MRDR technique was therefore used in the present study. Vitamin A deficiency was indicated by elevated DR:R ratios ($ 0·06) at the first MRDR test (day 18) in all children, and vitamin A liver stores had not increased significantly when re-evaluated 39 d after the intake of a single dose of 210 mmol retinyl palmitate; 'vitamin A capsule'. The mean DR:R ratio decreased slightly, from 0·156 (day 18) to 0·125 (day 57) and in only one child was the DR:R ratio normalised to , 0·06 after intake of the vitamin A capsule. However, this child had a DR:R ratio of 0·06 on day 18 and the decrease in DR:R ratio (to 0·057) was thus marginal. Although the MRDR test is not a quantitative measure of vitamin A status, most children in the present study had substantially elevated DR:R ratios at baseline, clearly indicating vitamin A deficiency. Under these conditions, it can be assumed that the single dose of 210 mmol retinyl palmitate was utilised rapidly in different body compartments, but did not provide enough retinol to improve liver stores. Thus, the lack of improvement in DR:R ratios is not surprising (Tanumihardjo, 2001) . No information is available on the dose of retinyl palmitate or other retinyl esters required to normalise DR:R ratios in individuals with vitamin A deficiency similar to the African children in the present study. However, the difference in response to added retinyl palmitate on erythrocyte incorporation of Fe from the labelled test meals before and after intake of a vitamin A capsule (single dose of 210 mmol retinyl palmitate) indicates changes in vitamin A status. These results highlight the need to develop sensitive techniques to better define vitamin A status at the cellular level.
In conclusion, added retinyl palmitate significantly decreased erythrocyte incorporation of Fe from the Fe-fortified test meal in children with vitamin A deficiency at baseline but had no significant influence 3 weeks after the intake of a high-dose vitamin A supplement (single dose of 210 mmol retinyl palmitate). These results indicate, indirectly, changes in vitamin A status after intake of the vitamin A supplement, although no significant improvement in vitamin A status could be detected by the MRDR technique. Intake of a single dose of 210 mmol retinyl palmitate did not improve vitamin A liver stores in the African children with vitamin A deficiency participating in the present study. More information is clearly needed on the doses of retinyl esters required to normalise DR:R ratios in children with vitamin A deficiency to optimise the health benefits of vitamin A supplementation programmes.
The results from the present study add to the contradictory information on the influence of dietary retinyl palmitate on Fe absorption as enhancing, inhibitory or as having no effect. The lack of conclusive data indicates the complexity of the interactions between vitamin A status, dietary vitamin A and Fe metabolism. 
